🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking forward to discussing with you ideas to boost resilience and wellbeing in oncology. Join us tomorrow at 10am and help shape strategies for oncology professionals.

Delighted to co-chair ESMO - Eur. Oncology preceptorship Ovarian cancer with Isabelle Ray-Coquard. Great talks and networking with young oncologists and experts. Thank you for excellent clinical case discussions! See you at ESMO Gynae cancer Congress feb 2023!

An honour to receive ⁦IJGC⁩ Award for the ATARI trial in clear cell and other rare Gynae cancers #IGCS2022. Thank you all research teams and patients- working together delivering novel trials. ⁦Follow us on Bluesky @ICR-CTSU⁩ ⁦⁦The Royal Marsden NHS Foundation Trust⁩

Practice-changing results: 1st phase 3 trial to show improvement in overall survival in platinum-resistant ovarian cancer (PROC). Mirvetuximab-setting a new standard of care for women with FR+ PROC. Thanks to all patients and researchers #ASCO23 The Royal Marsden NHS Foundation Trust NCRI Partnership

Thank you for congratulatory messages about Professorship The ICR The Royal Marsden NHS Foundation Trust An honour to be recognised for research and leadership-Thanks for believing in my potential, my team, friends, funders and patients ESMO - Eur. Oncology THE LADY GARDEN FOUNDATION

Honoured to receive fellow ESMO - Eur. Oncology (FESMO) award #ESMO2023 Privileged to serve the global oncology community and our patients The Royal Marsden NHS Foundation Trust The ICR THE LADY GARDEN FOUNDATION Andres Cervantes

Tisotumab Vedotin improves overall survival in recurrent/metastatic cervical cancer ESMO - Eur. Oncology Presidential. As ENGOTcx12 UK lead, thanks to all patients and trial teams globally-setting a new standard of care #ESMO2023 The Royal Marsden NHS Foundation Trust The ICR

⭐️ First of its kind ESMO - Eur. Oncology Resilience Task Force Special Session focusing on workforce sustainability in oncology. #ESMO23 The fully packed Hall Pamplona & discussions this morning prove that the issue is global 🌍. We as #OneOncologyCommunity need to take collective action!

An honour to deliver keynote lecture-ovarian cancer 3rd Indian Cancer Congress 2023 and be part of ISMPO ESMO - Eur. Oncology symposium- ‘genomics to the clinic’. Great networking at Indian Cancer Congress

Join me Thursday 25 January 2024 in London The Royal Society of Medicine to learn all the latest cutting-edge results setting new standards in endometrial cancer rsm.ac.uk/events/oncolog…

Big Thank you THE LADY GARDEN FOUNDATION for supporting gynae cancers awareness and research- 10 fabulous years! I am proud of the team The Royal Marsden NHS Foundation Trust The ICR Happy International Women’s Day!

Thanks ASCO for the discussant role opportunity- targeted therapy combinations in early phase trials hold promise for gynaecological cancers. ATR and PARP inhibitors in ovarian; dual mTORC1/2 and PD-1 inhibition in cervical cancer #ASCO24

Delighted to co-chair and welcome 975 delegates in Florence! #ESMOGynae24 3 days of education, scientific abstracts in gynaecological cancers and YO mentorship begins! ESMO - Eur. Oncology

Excellent discussions from leading experts and audience interaction in surgery for ovarian cancer session #ESMOGyn24 ESMO - Eur. Oncology ESGO

Honoured to co-chair joint European Society of Cardiology ESMO - Eur. Oncology ESC/ESMO session #ESCCongress2024- managing cancer treatment-related cardiac toxicities. Acute/long term and late onset side effects- more research needed for cancer survivors NIHR Royal Marsden BRC with @ICRLondon and CRF National Institute for Health and Care Research The Royal Society of Medicine Association of Cancer Physicians

Great session on ADCs in gynaecological cancers ESMO - Eur. Oncology #ESMO24 with wonderful faculty friends and audience questions Ilaria Colombo

Thanks to great panel and audience ESMO - Eur. Oncology #RTF #ESMO24 forum addressing burnout and resilience together. Join us at the first resilience ESMO workshop in Barcelona 31st Jan/1st Feb 2025 #ESMO4Carers

Great #ovariancancer master session #IGCS2024. Honour to co-chair with expert speakers- summarising hot topics IGCS

Honour to present #IGCS2024 plenary session ENGOTov60/RAMP201 phase 2 ESGO The GOG Foundation Inc. primary results in low grade serous ovarian cancer. Phase 3 RAMP301 enrolling globally! BGCS The Royal Marsden NHS Foundation Trust The ICR World Ovarian Cancer Day & WOCCoalition The Royal Society of Medicine

Huge success! Thanks to 64 participants from 31 countries 🌏 ESMO - Eur. Oncology Resilience Task Force workshop. Incredible positivity and drive to build resilience in oncology workforce globally #ESMO4Carers Jon Lim, MRCP PhD Ishwaria Subbiah, MD MS FASCO Christoph_Oing Miriam O'Connor